Skip to Main Content

Paper Details

Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium.
Cancer Discov
18
2021
Author NameAffiliation
Yana PikmanDana-Farber Cancer Institute
Yana PikmanBoston Children's Hospital
Sarah K TasianDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Sarah K TasianDepartment of Pediatrics and Abramson Cancer Center at the Perelman School of Medicine at the University of Pennsylvania
Cristina E TognonKnight Cancer Institute, Oregon Health and Science University
Matthew P JacobsonDepartment of Pharmaceutical Chemistry, University of California san francisco
Angela SuINSERM UMR , St Louis Hospital
Stephen P HungerDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Stephen P HungerDepartment of Pediatrics and Abramson Cancer Center at the Perelman School of Medicine at the University of Pennsylvania
Stephen P HungerDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Stephen P HungerDepartment of Pediatrics and Abramson Cancer Center at the Perelman School of Medicine at the University of Pennsylvania
Katherine A JanewayDana-Farber Cancer Institute
Katherine A JanewayBoston Children's Hospital
Jeffrey W TynerKnight Cancer Institute, Oregon Health and Science University
Mignon L LohBenioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierBoston Children's Hospital
Kimberly StegmaierBroad Institute of Massachusetts Institute of Technology and Harvard University
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierBoston Children's Hospital
Kimberly StegmaierBroad Institute of Massachusetts Institute of Technology and Harvard University
  • 1 - 21

Datasets